Novozymes AS (NVZMY)

  • A brief financial summary of Novozymes AS as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
NVZMY OTC Markets USD Delayed NVZMF OTC Markets USD Delayed NZYMBc BATS Europe DKK Delayed 0Q4U London DKK Real-time NZYMb Copenhagen DKK Real-time NZYMb Vienna EUR Real-time
51.88 +0.62 (+1.21%)
Delayed Data USD Disclaimer

NVZMY Financial Summary

Novozymes A/S reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was DKK 4,456 million compared to DKK 4,367 million a year ago. Net income was DKK 936 million compared to DKK 1,152 million a year ago. Basic earnings per share from continuing operations was DKK 3.38 compared to DKK 4.17 a year ago. Diluted earnings per share from continuing operations was DKK 3.37 compared to DKK 4.14 a year ago.For the nine months, sales was DKK 13,296 million compared to DKK 13,024 million a year ago. Net income was DKK 2,326 million compared to DKK 2,793 million a year ago. Basic earnings per share from continuing operations was DKK 8.4 compared to DKK 10.09 a year ago. Diluted earnings per share from continuing operations was DKK 8.37 compared to DKK 10.01 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
NVZMY Income Statement
NVZMY
Gross margin TTM 54.27%
Operating margin TTM 24.16%
Net Profit margin TTM 18%
Return on Investment TTM 16.23%
Total Revenue
Net Income
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Revenue 4,456 4,217 4,623 4,529
Gross Profit 2,398 2,336 2,503 2,436
Operating Income 1,184 1,011 1,200 942
Net Income 936 606 784 883

Customize

Clear All
0Selected
Please try another search
NVZMY Balance Sheet
NVZMY
Quick Ratio MRQ 0.79
Current Ratio MRQ 1.52
LT Debt to Equity MRQ 30.53%
Total Debt to Equity MRQ 49.39%
Total Assets
Total Liabilities
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Assets 28,538 28,228 28,284 27,983
Total Liabilities 13,648 14,429 14,998 13,755
Total Equity 14,890 13,799 13,286 14,228

Customize

Clear All
0Selected
Please try another search
NVZMY Cash Flow Statement
NVZMY
Cash Flow/Share TTM 13.05
Revenue/Share TTM 64.34
Operating Cash Flow 25.49%
Cash
Net Change in Cash
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Cash From Operating Activities 1,586 1,130 314 584
Cash From Investing Activities -486 -705 -339 -898
Cash From Financing Activities -977 -456 99 23
Net Change in Cash 127 -52 59 -336

Customize

Clear All
0Selected
Please try another search

* In Millions of DKK (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.